FCRL4 and infection: This is in line with what has been reported previously for HIV-infected patients in which treatment with anti-retroviral therapy also resulted in abrogation of FcRL4 expressing atypical B-cells [5,36], as well as for individuals infected with Schistosomes in which the frequency of atypical B-cells was increased during infection and decreased to normal levels following treatment [37].